MeSH tree: C20.111
Researcher Daan van der Vliet, together with colleagues from the Netherlands Institute for Neuroscience, Leiden University, and Utrecht University, has discovered an important mechanism that may be linked to severe progression ...
May 22, 2026
0
9
For ten years, the Fr1da study, coordinated by Helmholtz Munich, has been investigating whether early stages of type 1 diabetes in children can be detected in routine pediatric care. The latest evaluation shows that the screening ...
May 21, 2026
0
6
A new study offers clues as to why exercise can improve neurological symptoms in people with multiple sclerosis (MS). The study, led by investigators from Mass General Brigham and University Medical Center Hamburg-Eppendorf ...
May 21, 2026
0
17
Around one in every 100 people worldwide has vitiligo—a chronic, autoimmune skin condition that causes the skin to appear lighter in patches.
May 20, 2026
0
4
Using psychoactive substances for recreation, socialization or symptom self-management is common for many people living with multiple sclerosis. When used to self-manage symptoms, some psychoactive substances may provide ...
May 19, 2026
0
6
The U.S. Food and Drug Administration has approved a label expansion for Vyvgart (efgartigimod alfa-fcab) and Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) for the treatment of adult patients with (gMG). The ...
May 18, 2026
0
7
More than 1 million people across the United States live with multiple sclerosis (MS), a disease that affects the brain, optic nerves, and spine. MS is an unpredictable disorder, with symptoms—such as overwhelming fatigue, ...
May 18, 2026
0
225
Researchers from the University of Geneva (UNIGE) and Geneva University Hospitals (HUG) have reached a significant advance in the fight against type 1 diabetes. Using an innovative hydrogel that supports insulin-producing ...
May 18, 2026
0
16
Thomas Delong, Ph.D., moved to Colorado from Germany two decades ago intent on one thing: understanding the origin of type 1 diabetes (T1D) and finding ways to stop it. Diagnosed at age 12 with the disease that affects 9.5 ...
May 18, 2026
0
7
The University of Texas MD Anderson Cancer Center and CTMC, a joint venture between UT MD Anderson and Resilience, today announced that the Food and Drug Administration (FDA) has issued a 'safe to proceed' for the Investigational ...
May 15, 2026
0
6
